Skip to Main Content

Author Details

Benedikt Brors
German Cancer Research Center (DKFZ)
1997
238
67
PMIDPaper TitleJournal TitlePublished Year
36657444Integrated single-cell profiling dissects cell-state-specific enhancer landscapes of human tumor-infiltrating CD8<sup>+</sup> T cells.Mol Cell2023
37609075Immune cell type signature discovery and random forest classification for analysis of single cell gene expression datasets.Front Immunol2023
37679568Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant chemotherapy in PDAC.Nat Cancer2023
37908367Using single-cell chromatin accessibility sequencing to characterize CD4+ T cells from murine tissues.Front Immunol2023
37979172Chronic chromosome instability induced by Plk1 results in immune suppression in breast cancer.Cell Rep2023
37709492DNA-methylation signature accurately differentiates pancreatic cancer from chronic pancreatitis in tissue and plasma.Gut2023
36973454Neuroblastoma arises in early fetal development and its evolutionary duration predicts outcome.Nat Genet2023
37400172Single-cell transcriptomics and data analyses for prokaryotes-Past, present and future concepts.Adv Appl Microbiol2023
37273966Polygenic Risk Score in African populations: progress and challenges.F1000Res2023
37143403High-resolution transcriptomic and epigenetic profiling identifies novel regulators of COPD.EMBO J2023
37263303Spatially Resolved Multi-Omics Single-Cell Analyses Inform Mechanisms of Immune Dysfunction in Pancreatic Cancer.Gastroenterology2023
37009482Corrigendum: Clinical impact of molecular subtyping of pancreatic cancer.Front Cell Dev Biol2023
37495858Integrated genetic analyses of immunodeficiency-associated Epstein-Barr virus- (EBV) positive primary CNS lymphomas.Acta Neuropathol2023
36657444Integrated single-cell profiling dissects cell-state-specific enhancer landscapes of human tumor-infiltrating CD8<sup>+</sup> T cells.Mol Cell2023
37908367Using single-cell chromatin accessibility sequencing to characterize CD4+ T cells from murine tissues.Front Immunol2023
37709492DNA-methylation signature accurately differentiates pancreatic cancer from chronic pancreatitis in tissue and plasma.Gut2023
37609075Immune cell type signature discovery and random forest classification for analysis of single cell gene expression datasets.Front Immunol2023
37979172Chronic chromosome instability induced by Plk1 results in immune suppression in breast cancer.Cell Rep2023
37679568Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant chemotherapy in PDAC.Nat Cancer2023
37495858Integrated genetic analyses of immunodeficiency-associated Epstein-Barr virus- (EBV) positive primary CNS lymphomas.Acta Neuropathol2023
37143403High-resolution transcriptomic and epigenetic profiling identifies novel regulators of COPD.EMBO J2023
37009482Corrigendum: Clinical impact of molecular subtyping of pancreatic cancer.Front Cell Dev Biol2023
37273966Polygenic Risk Score in African populations: progress and challenges.F1000Res2023
36973454Neuroblastoma arises in early fetal development and its evolutionary duration predicts outcome.Nat Genet2023
37400172Single-cell transcriptomics and data analyses for prokaryotes-Past, present and future concepts.Adv Appl Microbiol2023
37263303Spatially Resolved Multi-Omics Single-Cell Analyses Inform Mechanisms of Immune Dysfunction in Pancreatic Cancer.Gastroenterology2023
34045664Whole-exome sequencing in eccrine porocarcinoma indicates promising therapeutic strategies.Cancer Gene Ther2022
35659150Rare Germline Variants Are Associated with Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment: A Pan Prostate Cancer Group Study.Eur Urol2022
35595301A scoping review of distributed ledger technology in genomics: thematic analysis and directions for future research.J Am Med Inform Assoc2022
35763870Gene expression-based prediction of pazopanib efficacy in sarcoma.Eur J Cancer2022
36274133Feasibility and outcome of reproducible clinical interpretation of high-dimensional molecular data: a comparison of two molecular tumor boards.BMC Med2022
35366909Correction to: Deconvolution of sarcoma methylomes reveals varying degrees of immune cell infiltrates with association to genomic aberrations.J Transl Med2022
35995769The antileukemic activity of decitabine upon PML/RARA-negative AML blasts is supported by all-trans retinoic acid: in vitro and in vivo evidence for cooperation.Blood Cancer J2022
35983950Bcl-x<sub>L</sub> as prognostic marker and potential therapeutic target in cholangiocarcinoma.Liver Int2022
35858618Inflammatory exposure drives long-lived impairment of hematopoietic stem cell self-renewal activity and accelerated aging.Cell Stem Cell2022
35918329Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneity.Nat Commun2022
35918316Transcriptomic diversity in human medullary thymic epithelial cells.Nat Commun2022
36481818Author Correction: Genomic footprints of activated telomere maintenance mechanisms in cancer.Nat Commun2022
34045664Whole-exome sequencing in eccrine porocarcinoma indicates promising therapeutic strategies.Cancer Gene Ther2022
35045690Comprehensive genomic analysis of refractory multiple myeloma reveals a complex mutational landscape associated with drug resistance and novel therapeutic vulnerabilities.Haematologica2022
35763870Gene expression-based prediction of pazopanib efficacy in sarcoma.Eur J Cancer2022
35366909Correction to: Deconvolution of sarcoma methylomes reveals varying degrees of immune cell infiltrates with association to genomic aberrations.J Transl Med2022
35595301A scoping review of distributed ledger technology in genomics: thematic analysis and directions for future research.J Am Med Inform Assoc2022
35659150Rare Germline Variants Are Associated with Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment: A Pan Prostate Cancer Group Study.Eur Urol2022
35858618Inflammatory exposure drives long-lived impairment of hematopoietic stem cell self-renewal activity and accelerated aging.Cell Stem Cell2022
36481818Author Correction: Genomic footprints of activated telomere maintenance mechanisms in cancer.Nat Commun2022
36274133Feasibility and outcome of reproducible clinical interpretation of high-dimensional molecular data: a comparison of two molecular tumor boards.BMC Med2022
35995769The antileukemic activity of decitabine upon PML/RARA-negative AML blasts is supported by all-trans retinoic acid: in vitro and in vivo evidence for cooperation.Blood Cancer J2022
35983950Bcl-x<sub>L</sub> as prognostic marker and potential therapeutic target in cholangiocarcinoma.Liver Int2022
35918329Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneity.Nat Commun2022
  • 1 - 50 of 476

Recommended Authors

Sander R van Hooff
Princess Maxima Center for Pediatric Oncology
Career Start Year 2008
Number of shared co-authors 6
Matti Nykter
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2006
Number of shared co-authors 16
Nathalie Pochet
Broad Institute of MIT and Harvard
Career Start Year 2004
Number of shared co-authors 1
Gabriela Alexe
Dana-Farber Cancer Institute
Career Start Year 2004
Number of shared co-authors 5
Steffen Durinck
Genentech Inc.
Career Start Year 2004
Number of shared co-authors 5
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 2
Andrew V Kossenkov
The Wistar Institute
Career Start Year 2003
Number of shared co-authors 1
Leslie Cope
Johns Hopkins University School of Medicine
Career Start Year 2003
Number of shared co-authors 7
F??tima Al-Shahrour
Spanish National Cancer Research Centre (CNIO)
Career Start Year 2003
Number of shared co-authors 10
Syed Haider
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 21
Olivier Elemento
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 17
Mikhail G Dozmorov
Virginia Commonwealth University
Career Start Year 2001
Number of shared co-authors 1
Yidong Chen
The University of Texas Health Science Center at San Antonio
Career Start Year 2001
Number of shared co-authors 8
Sven Bilke
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2001
Number of shared co-authors 2
Yan W Asmann
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 4
Lodewyk F A Wessels
University Medical Centre Mannheim, University of Heidelberg
Career Start Year 2000
Number of shared co-authors 26
Andrew J Gentles
Stanford Center for Biomedical Informatics Research, Stanford University
Career Start Year 1999
Number of shared co-authors 2
Celine Lefebvre
The Scripps Research Institute
Career Start Year 1999
Number of shared co-authors 1
Shawn Levy
HudsonAlpha Institute for Biotechnology
Career Start Year 1999
Number of shared co-authors 30
Mauro A A Castro
Federal University of Parana
Career Start Year 1997
Number of shared co-authors 5
Ole Christian Lingj??rde
University of Oslo
Career Start Year 1997
Number of shared co-authors 12
Sudhir Varma
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 3
Samuel Aparicio
University of British Columbia
Career Start Year 1993
Number of shared co-authors 30
Andrea Califano
Columbia University
Career Start Year 1993
Number of shared co-authors 28
Adam B Olshen
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 13
Kevin R Coombes
Medical College of Georgia
Career Start Year 1990
Number of shared co-authors 4
John Quackenbush
Harvard T. H. Chan School of Public Health
Career Start Year 1989
Number of shared co-authors 18
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 6
Todd R Golub
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 20
Pablo Tamayo
University of California San Diego
Career Start Year 1988
Number of shared co-authors 30

Collaborators

Roland Eils
Berlin Institute of Health (BIH) and Charite
Co-authored papers 76
Barbara Hutter
National Center for Tumor Diseases (NCT) Heidelberg
Co-authored papers 46
Stefan Fr??hling
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
Co-authored papers 42
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 31
Matthias Schlesner
University of Augsburg
Co-authored papers 29
Marc Zapatka
Co-authored papers 27
Peter Horak
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Co-authored papers 26
Peter Lichter
German Cancer Research Center (DKFZ)
Co-authored papers 26
Matthias Fischer
University Children's Hospital of Cologne
Co-authored papers 26
Christof von Kalle
Berlin Institute of Health at Charite-Universitatsmedizin Berlin
Co-authored papers 25
Sebastian Uhrig
National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ)
Co-authored papers 23
Frank Westermann
Co-authored papers 21
Stephan Wolf
Co-authored papers 21
André Oberthuer
Co-authored papers 20
Christoph Plass
German Cancer Research Center
Co-authored papers 19
Stefan M Pfister
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 18
Daniel H??bschmann
Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM)
Co-authored papers 18
Peter Schirmacher
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 17
David T W Jones
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 17
Jan O Korbel
European Bioinformatics Institute (EMBL-EBI)
Co-authored papers 17
Frank Berthold
Co-authored papers 17
Simon Kreutzfeldt
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Co-authored papers 16
Lars Feuerbach
German Cancer Research Center (DKFZ)
Co-authored papers 15
Dilafruz Juraeva
Co-authored papers 15
Andreas von Deimling
Co-authored papers 14
Dieter Weichenhan
German Cancer Research Center (DKFZ)
Co-authored papers 14
Olaf Witt
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 13
Kortine Kleinheinz
Co-authored papers 13
Chris Lawerenz
German Cancer Research Center (DKFZ)
Co-authored papers 12
Andrey Korshunov
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 11
Release 1.2